Questions around a case of in utero thrombosis in a premature child, concerning the management of anticoagulant treatments.

IF 1.6 4区医学 Q3 PHARMACOLOGY & PHARMACY

European journal of hospital pharmacy : science and practice Pub Date : 2024-10-25 DOI:10.1136/ejhpharm-2023-003826

Delphine Gerard, Arnaud Callies, Laure Simon, Catherine Ternisien, Sonia Prot-Labarthe

引用次数: 0

Abstract

We report the case of a preterm infant presenting a thrombosis, discovered on ultrasound at 22 weeks of gestational age and confirmed at birth following additional examinations. We describe the anticoagulant treatment of this patient by intravenous enoxaparin, tinzaparin and rivaroxaban, from questioning to practice.

查看原文本刊更多论文

关于一例早产儿童子宫内血栓形成的问题，关于抗凝治疗的管理。

我们报告了一例早产儿出现血栓的病例，该病例在胎龄22周时通过超声检查发现，并在额外检查后在出生时得到确认。我们描述了通过静脉注射依诺肝素、廷扎帕林和利伐沙班对该患者进行的抗凝治疗，从询问到实践。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European journal of hospital pharmacy : science and practice PHARMACOLOGY & PHARMACY-

CiteScore

3.40

自引率

5.90%

发文量

104

审稿时长

6-12 weeks

期刊介绍： European Journal of Hospital Pharmacy (EJHP) offers a high quality, peer-reviewed platform for the publication of practical and innovative research which aims to strengthen the profile and professional status of hospital pharmacists. EJHP is committed to being the leading journal on all aspects of hospital pharmacy, thereby advancing the science, practice and profession of hospital pharmacy. The journal aims to become a major source for education and inspiration to improve practice and the standard of patient care in hospitals and related institutions worldwide. EJHP is the only official journal of the European Association of Hospital Pharmacists.